Osteoporosis and fracture risk prevention in long-term glucocorticoid therapy.
Karcic
E
E
Karcic
A A
AA
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002118:Calcium / Q000008:administration & dosage; D002648:Child; D015914:Estrogen Replacement Therapy; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control*; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced* / Q000150:complications*; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D012189:Retrospective Studies; D012306:Risk; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011239:Prednisolone; D002118:Calcium